BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30826253)

  • 1. Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.
    Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jul; 4(7):610-618. PubMed ID: 30826253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
    Reed JL; Nugent AC; Furey ML; Szczepanik JE; Evans JW; Zarate CA
    Neuroimage Clin; 2018; 20():92-101. PubMed ID: 30094160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration.
    Evans JW; Szczepanik J; Brutsché N; Park LT; Nugent AC; Zarate CA
    Biol Psychiatry; 2018 Oct; 84(8):582-590. PubMed ID: 29580569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
    Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.
    Lundin NB; Sepe-Forrest L; Gilbert JR; Carver FW; Furey ML; Zarate CA; Nugent AC
    J Affect Disord; 2021 Jan; 279():239-249. PubMed ID: 33074143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
    McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant short-term and long-term brain effects during self-referential processing in major depression.
    Delaveau P; Jabourian M; Lemogne C; Allaïli N; Choucha W; Girault N; Lehericy S; Laredo J; Fossati P
    Psychiatry Res Neuroimaging; 2016 Jan; 247():17-24. PubMed ID: 26655583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
    Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
    J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression.
    Taraku B; Loureiro JR; Sahib AK; Zavaliangos-Petropulu A; Al-Sharif N; Leaver AM; Wade B; Joshi S; Woods RP; Espinoza R; Narr KL
    Brain Behav; 2024 Jun; 14(6):e3511. PubMed ID: 38894648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression.
    Rivas-Grajales AM; Salas R; Robinson ME; Qi K; Murrough JW; Mathew SJ
    Int J Neuropsychopharmacol; 2021 May; 24(5):383-391. PubMed ID: 33249434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
    Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.
    Gilbert JR; Yarrington JS; Wills KE; Nugent AC; Zarate CA
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):740-747. PubMed ID: 29668918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
    Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared facial emotion processing functional network findings in medication-naïve major depressive disorder and healthy individuals: detection by sICA.
    Li J; Kale Edmiston E; Tang Y; Fan G; Xu K; Wang F; Xu J
    BMC Psychiatry; 2018 Apr; 18(1):96. PubMed ID: 29636031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression.
    Ballard ED; Greenstein D; Reiss PT; Crainiceanu CM; Cui E; Duncan WC; Hejazi NS; Zarate CA
    Transl Psychiatry; 2024 Jun; 14(1):238. PubMed ID: 38834540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotion-Dependent Functional Connectivity of the Default Mode Network in Adolescent Depression.
    Ho TC; Connolly CG; Henje Blom E; LeWinn KZ; Strigo IA; Paulus MP; Frank G; Max JE; Wu J; Chan M; Tapert SF; Simmons AN; Yang TT
    Biol Psychiatry; 2015 Nov; 78(9):635-46. PubMed ID: 25483399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine specifically reduces cognitive symptoms in depressed patients: An investigation of associated neural activation patterns.
    Stippl A; Scheidegger M; Aust S; Herrera A; Bajbouj M; Gärtner M; Grimm S
    J Psychiatr Res; 2021 Apr; 136():402-408. PubMed ID: 33647855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.
    Furey ML; Drevets WC; Hoffman EM; Frankel E; Speer AM; Zarate CA
    JAMA Psychiatry; 2013 Mar; 70(3):280-90. PubMed ID: 23364679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of amygdala reactivity following rapidly acting interventions for major depression.
    Loureiro JRA; Leaver A; Vasavada M; Sahib AK; Kubicki A; Joshi S; Woods RP; Wade B; Congdon E; Espinoza R; Narr KL
    Hum Brain Mapp; 2020 May; 41(7):1699-1710. PubMed ID: 32115848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7T
    Evans JW; Lally N; An L; Li N; Nugent AC; Banerjee D; Snider SL; Shen J; Roiser JP; Zarate CA
    Neuropsychopharmacology; 2018 Aug; 43(9):1908-1914. PubMed ID: 29748628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.